GlaxoSmithKline UK

Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com

Patient Information Leaflet last updated on the eMC: 25/01/2012
PIL Hepatyrix

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 25/01/2012 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 28/07/2009 and displayed until 25/01/2012
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change due to harmonisation of PIL.
  • Change to date of revision
  • Change due to user-testing of patient information
Updated on 24/04/2007 and displayed until 28/07/2009
Reasons for adding or updating:
  • Change to date of revision
Updated on 22/11/2006 and displayed until 24/04/2007
Reasons for adding or updating:
  • Change of inactive ingredient
  • Change to date of revision
Updated on 27/10/2004 and displayed until 22/11/2006
Reasons for adding or updating:
  • Change to side-effects
Updated on 05/09/2003 and displayed until 27/10/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 09/05/2002 and displayed until 05/09/2003
Reasons for adding or updating:
  • Update to PIL

Active Ingredients/Generics

 
   hepatitis a vaccine
   typhoid vaccine